Ticker
VYGRCompany Name
VOYAGER THERAPEUTICS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Cash and Equivalents | Cash Ratio | Current Liabilities |
---|---|---|---|
6/30/2025 | $ 46.81M | 1.12 | $ 41.98M |
3/31/2025 | $ 77.63M | 1.93 | $ 40.21M |
12/31/2024 | $ 74.24M | 1.49 | $ 49.79M |
9/30/2024 | $ 112.53M | 2.55 | $ 44.21M |
6/30/2024 | $ 76.13M | 1.9 | $ 40.13M |
3/31/2024 | $ 143.08M | 1.97 | $ 72.55M |
12/31/2023 | $ 68.8M | 1.07 | $ 64.51M |
9/30/2023 | $ 65.27M | 1.06 | $ 61.69M |
6/30/2023 | $ 244.29M | 5.38 | $ 45.4M |
3/31/2023 | $ 268.32M | 13.46 | $ 19.94M |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
CashnEq / LiabilitesC
(=) Cash Ratio
Cash Ratio for VOYAGER THERAPEUTICS INC is calculated as follows: CashnEq [ $ 147.45M ] / LiabilitesC [ $ 42.05M ]
(=) Cash Ratio [ 3.51 ]
Minimum
Jun 30, 2022
Maximum
Mar 31, 2023
Average
Median
filtered constituents | 3.13K |
---|---|
min | 0 |
max | 2.69 |
average | 0.62 |
median | 0.39 |
std | 0.63 |